Randall H. Kramer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Randall H. Kramer has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Nobuaki Ozeki
From the Department of Endodontics, School of Dentistry, Aichi Gakuin University, Nagoya, Aichi 464-8651, Japan
3 shared publicationsBarry L. Ziober
2 shared publicationsHiroshi Nakamura
From the Department of Endodontics, School of Dentistry, Aichi Gakuin University, Nagoya, Aichi 464-8651, Japan
2 shared publicationsJoseph O. Humtsoe
2 shared publicationsQianming Chen
Department of Cell and Tissue Biology, University of California San Francisco, San Francisco, California, USA
2 shared publicationsAkiko Onishi
Department of Cell and Tissue Biology, University of California San Francisco, San Francisco, California 94143-0640, USA
1 shared publication
Latest Publications
- Open Access
- 1 May 2014
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 289 (20) , 14380-14391
Differentiation of Human Skeletal Muscle Stem Cells into Odontoblasts Is Dependent on Induction of α1 Integrin Expression
- 1 May 2014
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 289 (20) , 14380-14391
Open AccessDifferentiation of Human Skeletal Muscle Stem Cells into Odontoblasts Is Dependent on Induction of α1 Integrin Expression
- 27 October 2010
- Published by Springer Nature
- p. 1-19
Cell Adhesion Molecules in Carcinoma Invasion and Metastasis
- 27 October 2010
- Published by Springer Nature
- p. 1-19
Cell Adhesion Molecules in Carcinoma Invasion and Metastasis
- 1 April 2010
- Published by Elsevier in Experimental Cell Research
- Vol. 316 (6) , 951-965
Sdc1 negatively modulates carcinoma cell motility and invasion
- 1 April 2010
- Published by Elsevier in Experimental Cell Research
- Vol. 316 (6) , 951-965
Sdc1 negatively modulates carcinoma cell motility and invasion
- Open Access
- 23 November 2009
- Published by Springer Nature in Oncogene
- Vol. 29 (8) , 1214-1226
Differential epidermal growth factor receptor signaling regulates anchorage-independent growth by modulation of the PI3K/AKT pathway
Tumor cells are capable of surviving loss of nutrients and anchorage in hostile microenvironments. Under these conditions, adapting to specific signaling pathways may shift the balance between growth and cellular dormancy. Here, we report a mechanism by which epidermal growth factor receptor (EGFR) differentially modulates the phosphatidylinositol 3′-kinase (PI3K)/AKT pathway in cellular stress conditions. When carcinoma cells were cultured as multicellular aggregates (MCA), cyclin D1 was induced through a serum-dependent EGFR activating pathway, triggering cell proliferation. The expression of cyclin D1 required both EGFR-mediated ERK and AKT activation. In serum-starved MCAs, EGFR activation was associated with active ERK1/2, but not AKT, and failed to induce cyclin D1. Analysis revealed that, under serum-starved conditions, EGFR-Y1086 residue was poorly autophosphorylated and this correlated with failure to phosphorylate Gab1. Accordingly, the EGFR activation failed to induce EGFR/PI3K complex formation or AKT activation, preventing cyclin D1 induction. Furthermore, we show that in serum-starved MCA, expression of constitutively active AKT re-established cyclin D1 expression and induced proliferation in an EGFR-dependent manner. Thus, modulation of the PI3K/AKT pathway by context-dependent EGFR signaling may regulate tumor cell growth and dormancy.
- 23 November 2009
- Published by Springer Nature in Oncogene
- Vol. 29 (8) , 1214-1226
Open AccessDifferential epidermal growth factor receptor signaling regulates anchorage-independent growth by modulation of the PI3K/AKT pathway
Tumor cells are capable of surviving loss of nutrients and anchorage in hostile microenvironments. Under these conditions, adapting to specific signaling pathways may shift the balance between growth and cellular dormancy. Here, we report a mechanism by which epidermal growth factor receptor (EGFR) differentially modulates the phosphatidylinositol 3′-kinase (PI3K)/AKT pathway in cellular stress conditions. When carcinoma cells were cultured as multicellular aggregates (MCA), cyclin D1 was induced through a serum-dependent EGFR activating pathway, triggering cell proliferation. The expression of cyclin D1 required both EGFR-mediated ERK and AKT activation. In serum-starved MCAs, EGFR activation was associated with active ERK1/2, but not AKT, and failed to induce cyclin D1. Analysis revealed that, under serum-starved conditions, EGFR-Y1086 residue was poorly autophosphorylated and this correlated with failure to phosphorylate Gab1. Accordingly, the EGFR activation failed to induce EGFR/PI3K complex formation or AKT activation, preventing cyclin D1 induction. Furthermore, we show that in serum-starved MCA, expression of constitutively active AKT re-established cyclin D1 expression and induced proliferation in an EGFR-dependent manner. Thus, modulation of the PI3K/AKT pathway by context-dependent EGFR signaling may regulate tumor cell growth and dormancy.
- 1 January 2008
- Published by Elsevier in Experimental Cell Research
- Vol. 314 (2) , 377-386
STAT3 signaling is induced by intercellular adhesion in squamous cell carcinoma cells
- 1 January 2008
- Published by Elsevier in Experimental Cell Research
- Vol. 314 (2) , 377-386
STAT3 signaling is induced by intercellular adhesion in squamous cell carcinoma cells
- 1 February 2007
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 353 (1) , 54-59
Modulation of satellite cell adhesion and motility following BMP2-induced differentiation to osteoblast lineage
- 1 February 2007
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 353 (1) , 54-59
Modulation of satellite cell adhesion and motility following BMP2-induced differentiation to osteoblast lineage
- 1 December 2006
- Published by Elsevier in Experimental Cell Research
- Vol. 312 (20) , 4162-4180
α7 integrin expressing human fetal myogenic progenitors have stem cell-like properties and are capable of osteogenic differentiation
- 1 December 2006
- Published by Elsevier in Experimental Cell Research
- Vol. 312 (20) , 4162-4180
α7 integrin expressing human fetal myogenic progenitors have stem cell-like properties and are capable of osteogenic differentiation
- 18 January 2003
- Vol. 22 (5) , 2733-40
Oral mucosal carcinogenesis in SENCAR mice.
Animal models of oral carcinogenesis have been developed but most use the hamster buccal pouch or rat oral mucosa. With completion of human and murine genome sequencing, the development of a mouse model of oral carcinogenesis may prove useful for future genomic studies of oral carcinogenesis. To achieve this objective, 30 SENCAR mice were initiated by brush application of palatal, buccal and tongue mucosa with 200 nmol 7,12-dimethylbenz[a]anthracene (DMBA) using 3 treatment regimens, and promoted by brush application with 5 nmol 12-O-tetradecanoylphorbol-13-acetate (TPA) for a total of 28 weeks. Alternatively, 5 mice were treated with 0.5% 4-nitroquinoline-1-oxide (4NQO) alone by brush application for 28 weeks. There were another 6 control mice treated with vehicle alone. The tumor samples were analyzed for the presence of H-ras codon 61 gene mutations using a mutant-allele-specific amplification-polymerase chain reaction (MASA-PCR) technique. The results showed that among the group of 24 mice initiated with DMBA for 2 or 6 weeks, a range of papilliferous lesions were seen on the buccal mucosa comprising papillomas, papillomas with dysplasia and 7 squamous cell carcinomas (SCC). In those 6 mice initiated with 1 week of DMBA, only papillomas developed. In the 5 mice treated with 4NQO, one developed papillomas with dysplasia and two had SCCs in the tongue mucosa but not the buccal mucosa. Both carcinogens induced codon 61 mutation of the H-ras gene at a high frequency. The results indicated that DMBA/TPA and 4NQO in SENCAR mice reliably produced preneoplastic and malignant oral cavity lesions, which resemble the multistages for human oral carcinogenesis, and targeted to site-specific zones of the oral mucosa, namely the buccal mucosa and tongue, respectively. These results show that SENCAR mice can be used as a unique model of oral carcinogenesis with the potential for detailed molecular studies of neoplastic progression to SCC.
- 18 January 2003
- Vol. 22 (5) , 2733-40
Oral mucosal carcinogenesis in SENCAR mice.
Animal models of oral carcinogenesis have been developed but most use the hamster buccal pouch or rat oral mucosa. With completion of human and murine genome sequencing, the development of a mouse model of oral carcinogenesis may prove useful for future genomic studies of oral carcinogenesis. To achieve this objective, 30 SENCAR mice were initiated by brush application of palatal, buccal and tongue mucosa with 200 nmol 7,12-dimethylbenz[a]anthracene (DMBA) using 3 treatment regimens, and promoted by brush application with 5 nmol 12-O-tetradecanoylphorbol-13-acetate (TPA) for a total of 28 weeks. Alternatively, 5 mice were treated with 0.5% 4-nitroquinoline-1-oxide (4NQO) alone by brush application for 28 weeks. There were another 6 control mice treated with vehicle alone. The tumor samples were analyzed for the presence of H-ras codon 61 gene mutations using a mutant-allele-specific amplification-polymerase chain reaction (MASA-PCR) technique. The results showed that among the group of 24 mice initiated with DMBA for 2 or 6 weeks, a range of papilliferous lesions were seen on the buccal mucosa comprising papillomas, papillomas with dysplasia and 7 squamous cell carcinomas (SCC). In those 6 mice initiated with 1 week of DMBA, only papillomas developed. In the 5 mice treated with 4NQO, one developed papillomas with dysplasia and two had SCCs in the tongue mucosa but not the buccal mucosa. Both carcinogens induced codon 61 mutation of the H-ras gene at a high frequency. The results indicated that DMBA/TPA and 4NQO in SENCAR mice reliably produced preneoplastic and malignant oral cavity lesions, which resemble the multistages for human oral carcinogenesis, and targeted to site-specific zones of the oral mucosa, namely the buccal mucosa and tongue, respectively. These results show that SENCAR mice can be used as a unique model of oral carcinogenesis with the potential for detailed molecular studies of neoplastic progression to SCC.